David Hallal Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.
Get free email notifications about insider trading for David Hallal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Hallal. David Hallal is CEO in ALEXION PHARMACEUTICALS INC ($ALXN) and Chief Operating Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Chief Commercial Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP. Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and Sr. VP Comm Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and Sr. VP Comm. Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP Commercial Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, Global Commerical Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP. Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in Seer, Inc. ($SEER) and Director in Scholar Rock Holding Corp ($SRRK) and Chief Executive Officer in Allovir, Inc. ($ALVR) and Director in iTeos Therapeutics, Inc. ($ITOS).
David Hallal in ALEXION PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Hallal: CEO, Chief Operating Officer, EVP, Chief Commercial Officer, EVP. Global Commercial Ops, SVP. Global Commercial Ops, SVP, Global Commerical Ops, SVP, Global Commercial Ops, SVP Commercial Ops, Americas, Sr. VP Comm Ops, Americas, Sr. VP Comm. Ops, America
Holdings: 189,266 shares
Current Value: $24,173,054
Latest Transaction: Aug 10 2016
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David Hallal in ALEXION PHARMACEUTICALS, INC.
Sentiment: All, ALXN, ALVR, ITOS, SRRK, SEER
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 51.80 | 10,000 | 518,000 | 7,770 | 17.8 K to 7.8 K (-56.27 %) |
| Mar 04 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Buy | M | 16.32 | 10,000 | 163,200 | 17,770 | 7.8 K to 17.8 K (+128.70 %) |
| Feb 18 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 47.93 | 6,242 | 299,179 | 7,770 | 14 K to 7.8 K (-44.55 %) |
| Feb 01 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | A | 45.80 | 50,000 | 2,290,000 | 50,000 | |
| Feb 01 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Grant | A | 0.00 | 6,000 | 0 | 14,012 | 8 K to 14 K (+74.89 %) |
| Jan 21 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 47.22 | 227 | 10,719 | 8,012 | 8.2 K to 8 K (-2.76 %) |
| Jan 12 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 47.78 | 1,088 | 51,985 | 8,239 | 9.3 K to 8.2 K (-11.67 %) |
| Dec 21 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 47.79 | 916 | 43,776 | 9,327 | 10.2 K to 9.3 K (-8.94 %) |
| Dec 15 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | S | 16.32 | 10,000 | 163,200 | 68,128 | |
| Dec 15 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 46.40 | 10,000 | 464,000 | 10,243 | 20.2 K to 10.2 K (-49.40 %) |
| Dec 15 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Buy | M | 16.32 | 10,000 | 163,200 | 20,243 | 10.2 K to 20.2 K (+97.63 %) |
| Jul 28 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Sr. VP Comm Ops, Am ... | Sell | S | 43.00 | 8,640 | 371,520 | 10,243 | 18.9 K to 10.2 K (-45.76 %) |
| Jul 17 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Sr. VP Comm Ops, Am ... | Sell | S | 38.96 | 238 | 9,272 | 18,883 | 19.1 K to 18.9 K (-1.24 %) |
| Jun 23 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Sr. VP Comm Ops, Am ... | Sell | S | 38.47 | 789 | 30,353 | 19,121 | 19.9 K to 19.1 K (-3.96 %) |
| Jun 12 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Sr. VP Comm. Ops, A ... | Sell | S | 38.00 | 3,590 | 136,420 | 19,910 | 23.5 K to 19.9 K (-15.28 %) |